Journals Library

An error occurred retrieving publication content to display, please try again.

Page not found (404)

Sorry - the page you requested could not be found.

Please choose a page from the navigation or try a website search above to find the information you need.

This study concluded that for ODEP 10A* prostheses it is safe to disinvest in routine follow-up in the 1- to 10-year period after non-complex hip and knee replacement.

{{author}}{{author}}{{($index > metadata.AuthorsAndEtalArray.length-1) ? ',' : '.'}}

Sarah R Kingsbury 1,2, Lindsay K Smith 3, Carolyn J Czoski Murray 4, Rafael Pinedo-Villanueva 5, Andrew Judge 6,7,8, Robert West 4, Chris Smith 4, Judy M Wright 4, Nigel K Arden 5,6, Christine M Thomas 2, Spryos Kolovos 5, Farag Shuweihdi 4, Cesar Garriga 5, Byron KY Bitanihirwe 4, Kate Hill 4, Jamie Matu 1,4, Martin Stone 2,9, Philip G Conaghan 1,2,*

1 Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK
2 NIHR Leeds Biomedical Research Centre, Leeds, UK
3 UK Faculty of Health and Applied Sciences, University of the West of England, Bristol, UK
4 Leeds Institute of Health Sciences, University of Leeds, Leeds, UK
5 Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
6 MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK
7 Pharmaco- and Device-Epidemiology Group, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
8 Translational Health Sciences, University of Bristol, Bristol, UK
9 Leeds Teaching Hospitals NHS Trust, Leeds, UK
* Corresponding author Email: p.conaghan@leeds.ac.uk

Declared competing interests of authors: Lindsay K Smith reports grants from the National Institute for Health and Care Research (NIHR) (NIHR CAT CL-2013-04-005). Andrew Judge reports personal fees from Freshfields Bruckhaus Deringer LLP (London, UK) and Anthera Pharmaceuticals, Inc. (Hayward, CA, USA) and other from the NIHR Programme Grants for Applied Research programme, outside the submitted work. Robert West reports Health and Social Care Delivery Research (HSDR) Researcher Led Panel membership (2017–21), Public Health Research Funding Board membership (2011–17) and HSDR Funding Committee (Bevan) membership (2020–1). Chris Smith reports directorship of PrivacyForge Ltd (London, UK), which provides software products, consulting services and education and training services in the area of data privacy. Nigel K Arden reports grants from Merck & Co. Inc. (Kenilworth, NJ, USA) during the conduct of the study, and personal fees from Pfizer Inc. (New York, NY, USA), Eli Lilly and Company (Indianapolis, IN, USA) and Bristows LLP (London, UK).

Funding: {{metadata.Funding}}

{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}

https://doi.org/{{metadata.DOI}}

Citation:{{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al. ' : ''}}. {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})

Crossmark status check

Report Content

The full text of this issue is available as a PDF document from the Toolkit section on this page.

The full text of this issue is available as a PDF document from the Toolkit section on this page.

If you would like to receive a notification when this project publishes in the NIHR Journals Library, please submit your email address below.

Responses to this report

No responses have been published.

 

If you would like to submit a response to this publication, please do so using the form below:

Comments submitted to the NIHR Journals Library are electronic letters to the editor. They enable our readers to debate issues raised in research reports published in the Journals Library. We aim to post within 14 working days all responses that contribute substantially to the topic investigated, as determined by the Editors.  Non-relevant comments will be deleted.

Your name and affiliations will be published with your comment.

Once published, you will not have the right to remove or edit your response. The Editors may add, remove, or edit comments at their absolute discretion.

By submitting your response, you are stating that you agree to the terms & conditions

An error has occurred in processing the XML document